Biometric Screenings: The Most Underrated Line Item in Your Benefits Budget

If you're an HR or benefits leader, you've almost certainly seen biometric screenings on a vendor proposal at some point. Maybe you've offered them. Maybe you've quietly cut them when budgets tightened. Maybe they live in a folder somewhere labeled "things we should probably do something about next year."

Here's the case for moving them back to the top of the list — and doing them well.

What a biometric screening actually is (and isn't)

A biometric screening is a short, standardized health check that captures a handful of clinical data points known to predict the most expensive and life-altering chronic conditions. A typical screening takes about fifteen minutes and includes:

• Blood pressure
• Total cholesterol, HDL, LDL, and triglycerides
• Fasting blood glucose or A1C
• Body composition measurements (height, weight, BMI, waist circumference)
• Sometimes additional markers: cotinine for tobacco use, liver enzymes, vitamin D

It is not a physical. It is not a diagnosis. It does not replace primary care. What it does is something most healthcare systems are structurally bad at doing: it catches the silent stuff. The conditions that don't hurt yet. The numbers that are quietly drifting in the wrong direction long before anyone has a symptom.

Why this matters more than it sounds like it should

The five conditions that drive the majority of an employer's healthcare spend — hypertension, diabetes, heart disease, certain cancers, and obesity-related complications — share two characteristics. They are all clinically detectable years before they become acute, and the people who have them very often do not know they have them.

Roughly one in three adults with high blood pressure doesn't know it. About one in five adults with diabetes is undiagnosed. Pre-diabetes is even worse: the CDC estimates that more than 80% of people with pre-diabetes have no idea. These aren't people who are ignoring their doctors. These are people who feel fine, are getting through their day, and have no reason to think anything is wrong.

A biometric screening is, in many cases, the first time anyone has told them otherwise.

What actually happens with the data

This is where biometric screenings either deliver enormous value or quietly waste your money, depending on how the program is run.

A screening that ends with a printout and a handshake is mostly theater. The employee walks out with a piece of paper, files it in a kitchen drawer, and a year later you have very little to show for the investment. Aggregate data may go to a wellness vendor. Maybe a dashboard gets generated. The employee who needed a follow-up never gets one.

A screening connected to actual care is a different product entirely. When results trigger an immediate conversation with a clinician — onsite, virtual, doesn't matter — and that clinician can prescribe, refer, schedule a follow-up, or simply explain what the numbers mean, the entire economics of the program change. The screening stops being a data collection exercise and becomes the front door to early intervention.

The difference between these two models is, candidly, the difference between checking a box and saving lives. Both can technically be called "biometric screenings" on a benefits brochure. They are not the same thing.

What the ROI actually looks like

The published research on biometric screening ROI is genuinely mixed, and any vendor who tells you otherwise is selling you something. Standalone screenings without clinical follow-through often show modest or negligible returns. Screenings embedded in a broader primary care or clinical engagement model consistently show stronger results — typically through three mechanisms:

The first is medical claims avoidance. A hypertension diagnosis caught at a screening and managed with a $4 generic medication has a different cost trajectory than a hypertension diagnosis made in an emergency room after a stroke. The math on this is brutal and well-documented.

The second is reduced absenteeism and presenteeism. Employees managing diagnosed conditions miss less work than employees with undiagnosed conditions. They also show up more focused. This rarely shows up in the claims data, but it shows up in productivity if you're measuring it.

The third is stop-loss and renewal protection. A single catastrophic claim — late-stage cancer, end-stage renal disease, a major cardiac event — can move a renewal by double digits. The biometric screening that flagged the early signal three years prior costs roughly nothing in comparison.

Designing a screening program that actually works

If you're building or rebuilding a screening program, the variables that matter most are not the ones vendors usually emphasize.

Participation rate is everything. A screening program that captures 30% of your population is largely a screening program for the people who would have gotten screened anyway. The employees you most need to reach — the ones who haven't seen a doctor in years, who don't have a primary care physician, who are quietly carrying the highest risk — are the hardest ones to bring through the door. Convenience is the single biggest lever. Onsite screenings during work hours consistently outperform "go to a lab on your own time" models by a wide margin. Incentives help, but only at the margins.

Clinical follow-through is the second most important factor. Ask any vendor how abnormal results are handled. Listen carefully to the answer. If the answer involves a portal, a printout, or a "we recommend they see their doctor," you are paying for a data collection service. If the answer involves a same-day or same-week conversation with a clinician who can take action, you are paying for healthcare.

Data privacy and trust matter more than people admit. Employees who don't trust what happens to their results don't show up. Period. The program needs to be transparent about what the employer sees (aggregate, de-identified) versus what stays between the employee and the clinician (everything individual). If your workforce thinks the screening is a way for the company to find reasons to raise their premiums, participation will collapse and the people most at risk will be the first to opt out.

Frequency should be annual, minimum. Numbers drift. A clean reading this year doesn't mean a clean reading next year. The value compounds over time as you build a longitudinal picture of each employee's health.

The decision framework

When evaluating biometric screening as a line item, the right question is not "do biometric screenings work?" The honest answer to that question is "sometimes, depending on how they're done." The better question is:

Does the screening program we're considering connect every abnormal result to a clinician who can take action, in a way that's convenient enough that our highest-risk employees will actually participate?

If the answer is yes, biometric screenings are one of the highest-leverage investments on your benefits line — a small annual cost that compounds into avoided claims, retained talent, and, occasionally, a phone call from an employee saying thank you, I had no idea.

If the answer is no, you're paying for paperwork.

The good news is that the gap between those two outcomes is almost entirely a design choice. Programs that work share a small number of features, and any of them can be built into your benefits offering with the right partner.

That's the conversation worth having.